IDSA/AASLD Response to Cochrane Review on Direct-Acting Antivirals for Hepatitis C.
Publication
, Journal Article
Powderly, WG; Naggie, S; Kim, AY; Vargas, HE; Chung, RT; Lok, AS
Published in: Clin Infect Dis
November 13, 2017
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Clin Infect Dis
DOI
EISSN
1537-6591
Publication Date
November 13, 2017
Volume
65
Issue
11
Start / End Page
1773 / 1775
Location
United States
Related Subject Headings
- Microbiology
- Humans
- Hepatitis C, Chronic
- Hepatitis A
- Hepacivirus
- Antiviral Agents
- 3202 Clinical sciences
- 11 Medical and Health Sciences
- 06 Biological Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Powderly, W. G., Naggie, S., Kim, A. Y., Vargas, H. E., Chung, R. T., & Lok, A. S. (2017). IDSA/AASLD Response to Cochrane Review on Direct-Acting Antivirals for Hepatitis C. Clin Infect Dis, 65(11), 1773–1775. https://doi.org/10.1093/cid/cix620
Powderly, William G., Susanna Naggie, Arthur Y. Kim, Hugo E. Vargas, Raymond T. Chung, and Anna S. Lok. “IDSA/AASLD Response to Cochrane Review on Direct-Acting Antivirals for Hepatitis C.” Clin Infect Dis 65, no. 11 (November 13, 2017): 1773–75. https://doi.org/10.1093/cid/cix620.
Powderly WG, Naggie S, Kim AY, Vargas HE, Chung RT, Lok AS. IDSA/AASLD Response to Cochrane Review on Direct-Acting Antivirals for Hepatitis C. Clin Infect Dis. 2017 Nov 13;65(11):1773–5.
Powderly, William G., et al. “IDSA/AASLD Response to Cochrane Review on Direct-Acting Antivirals for Hepatitis C.” Clin Infect Dis, vol. 65, no. 11, Nov. 2017, pp. 1773–75. Pubmed, doi:10.1093/cid/cix620.
Powderly WG, Naggie S, Kim AY, Vargas HE, Chung RT, Lok AS. IDSA/AASLD Response to Cochrane Review on Direct-Acting Antivirals for Hepatitis C. Clin Infect Dis. 2017 Nov 13;65(11):1773–1775.
Published In
Clin Infect Dis
DOI
EISSN
1537-6591
Publication Date
November 13, 2017
Volume
65
Issue
11
Start / End Page
1773 / 1775
Location
United States
Related Subject Headings
- Microbiology
- Humans
- Hepatitis C, Chronic
- Hepatitis A
- Hepacivirus
- Antiviral Agents
- 3202 Clinical sciences
- 11 Medical and Health Sciences
- 06 Biological Sciences